Universal 'Off-the-Shelf' cell therapy tested for Tough-to-Treat blood cancer
NCT ID NCT06663046
Summary
This early-phase study is testing a new type of cell therapy called UWD-00B for people with multiple myeloma that has come back or stopped responding to standard treatments. The therapy uses genetically modified immune cells designed to target and attack the cancer. Researchers aim to see if this 'off-the-shelf' treatment is safe and shows early signs of helping control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYLEOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Affiliated Hospital of Xi'an Jiaotong University
RECRUITINGXi'an, Shaanxi, 710061, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.